Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
$834.00 *NOT AVAILABLE to AL, ID, AK, HI This past June, the US Food and Drug Administration approved GLP-1, a glucagon-like peptide 1 receptor agonist, for chronic weight management, based on results from the four 68-week STEP (Treatment Effect in People with obesity) trials
Why compounding is legal and regulated
Some patients reach their goal weight and maintain it on a stable microdose
The FDAs vote follows a 2023 reclassification that pulled BPC-157 out of the reach of licensed compounding pharmacies
Some patients report mixed experiences with individual providers, but overall care quality remains strong
US$ 25.54
US$ 29.46
US$ 26.74
US$ 22.99
US$ 29.81
US$ 22.99
US$ 29.20
US$ 27.63
